articleHuman Gene TherapyJan 22, 2010Closed access

Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors

Genethon (France) · Sorbonne Université · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Adeno-associated viruses (AAVs) are small, nonenveloped single-stranded DNA viruses that require helper viruses to facilitate efficient replication. Despite the presence of humoral responses to the wild-type AAV in humans, AAV remains one of the most promising candidates for therapeutic gene transfer to treat many genetic and acquired diseases. Characterization of the IgG subclass responses to AAV and study of the prevalence of both IgG and neutralizing factors to AAV types 1, 2, 5, 6, 8, and 9 in the human population are of importance for the development of new strategies to overcome these immune responses. Natural exposure to AAV types 1, 2, 5, 6, 8, and 9 can result in the production of antibodies from all…

Citation impact

941
total citations
FWCI
24.18
Percentile
100%
References
60
Citations per year

Authors

7

Topics & keywords

Keywords
  • Adeno-associated virus
  • Virology
  • Genetic enhancement
  • Biology
  • Antibody
  • Population
  • Neutralizing antibody
  • Immunology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.